PSCR (Proto Script Pharmaceutical) ROCE %: 0.00% (As of Sep. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Proto Script Pharmaceutical ROCE %?

Proto Script Pharmaceutical PSCR ROCE % is 0.00% as of Sep. 2017.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Proto Script Pharmaceutical's annualized ROCE % for the quarter that ended in Sep. 2017 was 0.00%.

Proto Script Pharmaceutical  (OTCPK:PSCR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Proto Script Pharmaceutical ROCE % Related Terms

Proto Script Pharmaceutical ROCE % Historical Data

* Premium members only.

The historical data trend for Proto Script Pharmaceutical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proto Script Pharmaceutical ROCE % Chart

Proto Script Pharmaceutical Annual Data
Trend May12 May13 May14 May15 May16
ROCE %
0.00 -193.94 -160.98 0.00 0.00

Proto Script Pharmaceutical Quarterly Data
Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Sep16 Dec16 Mar17 Jun17 Sep17
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Proto Script Pharmaceutical ROCE % Calculation

Proto Script Pharmaceutical's annualized ROCE % for the fiscal year that ended in May. 2016 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: May. 2016 )  (A: May. 2015 )(A: May. 2016 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: May. 2016 )  (A: May. 2015 )(A: May. 2016 )
=-0.033/( ( (0.001 - 0.045) + (0.012 - 0.089) )/ 2 )
=-0.033/( (-0.044+-0.077)/ 2 )
=-0.033/-0.0605
=54.55 %

Proto Script Pharmaceutical's ROCE % of for the quarter that ended in Sep. 2017 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2017 )  (Q: Jun. 2017 )(Q: Sep. 2017 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2017 )  (Q: Jun. 2017 )(Q: Sep. 2017 )
=-0.664/( ( (0.166 - 1.324) + (0.235 - 1.676) )/ 2 )
=-0.664/( ( -1.158 + -1.441 )/ 2 )
=-0.664/-1.2995
=0 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2017) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.00% mean?
Proto Script Pharmaceutical (PSCR) has a ROCE % of 0.00% as of Sep. 2017.
Is Proto Script Pharmaceutical's ROCE % too high?
Proto Script Pharmaceutical's current ROCE % is 0.00%.
How does Proto Script Pharmaceutical's ROCE % compare to EXCC and NXES?
Proto Script Pharmaceutical's ROCE % of 0.00% can be compared against companies in the Business Services industry. The industry median ROCE % is 8.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Business Services company?
The median ROCE % among Business Services companies is 8.96, based on 1,069 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Business Services industry, the median ROCE % is 8.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Proto Script Pharmaceutical's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proto Script Pharmaceutical stock overvalued right now?
Proto Script Pharmaceutical (PSCR) has a current ROCE % of 0.00%. The current ROCE % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Proto Script Pharmaceutical (PSCR), the current ROCE % is 0.00% as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Proto Script Pharmaceutical Business Description

Address 9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730
Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.